These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8985330

  • 21. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD, Hsieh JJ, Ruf IK, Rawlins DR, Hayward SD.
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [Abstract] [Full Text] [Related]

  • 22. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y, Sheen TS, Lu J, Huang YT, Chen JY, Yang CS, Tsai CH.
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Woisetschlaeger M, Yandava CN, Furmanski LA, Strominger JL, Speck SH.
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1725-9. PubMed ID: 2155423
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity.
    Yandava CN, Speck SH.
    J Virol; 1992 Sep; 66(9):5646-50. PubMed ID: 1323716
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Epigenetic regulation of latent Epstein-Barr virus promoters.
    Takacs M, Banati F, Koroknai A, Segesdi J, Salamon D, Wolf H, Niller HH, Minarovits J.
    Biochim Biophys Acta; 2010 Sep; 1799(3-4):228-35. PubMed ID: 19853674
    [Abstract] [Full Text] [Related]

  • 33. trans-Repression of protein expression dependent on the Epstein-Barr virus promoter Wp during latency.
    Hughes DJ, Dickerson CA, Shaner MS, Sample CE, Sample JT.
    J Virol; 2011 Nov; 85(21):11435-47. PubMed ID: 21865378
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines.
    Schaefer BC, Strominger JL, Speck SH.
    J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
    Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF.
    J Virol; 1998 Sep; 72(9):7075-83. PubMed ID: 9696800
    [Abstract] [Full Text] [Related]

  • 39. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G.
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717
    [Abstract] [Full Text] [Related]

  • 40. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.
    Jin XW, Speck SH.
    J Virol; 1992 May; 66(5):2846-52. PubMed ID: 1313905
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.